D M Goldenberg
-
- Radiopharmaceutical Chemistry and Applications 38
- Monoclonal and Polyclonal Antibodies Research 38
- Medical Imaging Techniques and Applications 8
- Oncology top 5%
- HER2/EGFR in Cancer Research 7
- Cancer Treatment and Pharmacology 6
- Immunology top 10%
- Biotechnology top 5%
- Cancer Research and Treatments 14
-
- Glycosylation and Glycoproteins Research 20
-
- Medical Imaging and Pathology Studies 7
- Co-authors
- F. James PrimusR M SharkeyF. H. DeLandSidney BennettRobert M. SharkeyH. J. HansenRosalyn D. BlumenthalM. Jules Mattes
- Journals
- Cancer Research (6 papers)Journal of Clinical Oncology (6 papers)Proceedings of the National Academy of Sciences (4 papers)
- Partner nations
- United StatesGermanyBelgium
In The Last Decade
D M Goldenberg
83 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 91
- Radiology, Nuclear Medicine and Imaging 1.4k
- Oncology 699
- Immunology 286
- Pathology and Forensic Medicine 238
- Biotechnology 106
Countries citing papers authored by D M Goldenberg
This map shows the geographic impact of D M Goldenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D M Goldenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D M Goldenberg more than expected).
Fields of papers citing papers by D M Goldenberg
This network shows the impact of papers produced by D M Goldenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D M Goldenberg. The network helps show where D M Goldenberg may publish in the future.
Co-authorship network
The 25 scholars most cited alongside D M Goldenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 51 | |
| 2 | 2019 | 3 | |
| 3 | 2016 | 1 | |
| 4 | 2010 | 2 | |
| 5 | 2005 | 39 | |
| 6 | Tumor-specific dose scheduling of bimodal radioimmunotherapy and chemotherapy. | 2004 | 10 |
| 7 | 2003 | 24 | |
| 8 | 1997 | 6 | |
| 9 | 1997 | 1 | |
| 10 | 1997 | 5 | |
| 11 | 1996 | 92 | |
| 12 | 1995 | 14 | |
| 13 | 1994 | 29 | |
| 14 | Murine monoclonal antibodies against carcinoembryonic antigen: immunological, pharmacokinetic, and targeting properties in humans. | 1990 | 49 |
| 15 | 1989 | 24 | |
| 16 | Radioimmunotherapy of the GW-39 human colonic tumor xenograft with 131I-labeled murine monoclonal antibody to carcinoembryonic antigen. | 1987 | 54 |
| 17 | 1981 | 105 | |
| 18 | 1979 | 28 | |
| 19 | 1970 | 11 | |
| 20 | 1970 | 1 |
About D M Goldenberg
D M Goldenberg is a scholar working on Radiology, Nuclear Medicine and Imaging, Biotechnology, Oncology, Immunology and Pulmonary and Respiratory Medicine, having authored 85 papers that have together received 2.1k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (38 papers), Monoclonal and Polyclonal Antibodies Research (38 papers), Glycosylation and Glycoproteins Research (20 papers), Cancer Research and Treatments (14 papers), Medical Imaging Techniques and Applications (8 papers), HER2/EGFR in Cancer Research (7 papers), Medical Imaging and Pathology Studies (7 papers) and Cancer Treatment and Pharmacology (6 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.4k citations), Oncology (699 citations), Immunology (286 citations), Pathology and Forensic Medicine (238 citations) and Biotechnology (106 citations). D M Goldenberg has collaborated with scholars based in United States, Germany and Belgium. Frequent co-authors include F. James Primus, R M Sharkey, F. H. DeLand, Sidney Bennett, Robert M. Sharkey, H. J. Hansen, Rosalyn D. Blumenthal, M. Jules Mattes, Thomas M. Behr and Morton K. Schwartz. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Proceedings of the National Academy of Sciences, JNCI Journal of the National Cancer Institute and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.